Bevacizumab increases the risk of severe congestive heart failure in cancer patients: an up-to-date meta-analysis with a focus on different subgroups (Q38237318)
Jump to navigation
Jump to search
scientific article published on October 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab increases the risk of severe congestive heart failure in cancer patients: an up-to-date meta-analysis with a focus on different subgroups |
scientific article published on October 2014 |
Statements
1 reference
Bevacizumab increases the risk of severe congestive heart failure in cancer patients: an up-to-date meta-analysis with a focus on different subgroups (English)
1 reference
Wei-Xiang Qi
1 reference
Shen Fu
1 reference
Qing Zhang
1 reference
Xiao-Mao Guo
1 reference
1 October 2014
1 reference
1 reference
34
1 reference
10
1 reference
681-690
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference